Mar 04,2016

LabStyle Innovations Announces Uplisting to NASDAQ and Capital Raise of $8.5 Million

LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective March 4, 2016, and will trade under the symbols "DRIO" and "DRIOW", respectively. The aggregate gross proceeds to LabStyle from the public offering and private placement are expected to be $8.5 million, prior to deducting underwriting discounts, commissions and other estimated offering expenses.

View Analyst & Ambassador Comments
Go to original news
Mar 09,2016

LabStyle Innovations Granted U.S. Patent Expanding IP for Fluids Testing into Industrial Applications via Mobile Devices and Apps

LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038 titled, "Fluids testing apparatus and methods of use.". The invention addresses mobile, hand held, miniature laboratory systems and testing of fluids including bodily fluids such as blood, urine, saliva, and amniotic fluid, as well as non-bodily fluids for industrial, defense and security applications including environmental and food safety.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Mar 14,2016

Dexcom G5® Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch

Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System will support the Apple Watch enabling users to monitor their G5 Mobile glucose data using the app with one glance of their wrist. Users, as well as parents and caregivers, will be able to discreetly receive glucose readings and trends, alerts and notifications on Apple Watch, which syncs data directly from iPhone.

PRODUCT

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 14,2016

Tandem Diabetes Care Announces Appointment of Dr. Henry Anhalt as Board Member

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today announced the appointment of Henry Anhalt, DO, FACOP, FACE as an independent member of its board of directors.

View Analyst & Ambassador Comments
Go to original news
Mar 15,2016

LabStyle Innovations' Dario Blood Glucose Monitoring System Online e-Store and Membership Program Live in USA

LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the national availability of Dario in the U.S. The U.S. rollout follows the U.S. Food and Drug Administration's 510(k) clearance of the Dario in December 2015.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Mar 15,2016

Nemaura Medical Announces receipt of notification of CE Approval for its sugarBEAT® Continuous Glucose Monitoring System

Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive wireless continuous glucose monitoring (“CGM”) system known as sugarBEAT®, announced today that it has received notification of CE Approval for its sugarBEAT® system from its European Notified Body.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 16,2016

Insulet Names Aiman Abdel-Malek, Ph.D. Senior Vice President of Advanced Technology and Engineering

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced the appointment of Aiman Abdel-Malek, Ph.D. as Senior Vice President of Advanced Technology and Engineering, effective March 28, 2016.

View Analyst & Ambassador Comments
Go to original news
Mar 18,2016

Brighter opens new customer segment for jDome

Brighter hires two dedicated sales people and opens a competence center for jDome® and people with disabilities. Sales of jDome BikeAround™, Brighter's activity-promoting aid with the help of innovative technology, activates both heart and brain in a safe and secure way, is developing very strongly in elderly care with both municipal and private customers.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Mar 30,2016

Insulet Corporation to Announce First Quarter 2016 Financial Results on April 28, 2016

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced plans to release its financial results for the first quarter of 2016 on April 28, 2016 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Mar 31,2016

Brighter publishes the financial result of 2015

The Company's operating income amounted to SEK 15,722 thousand (SEK 13,843 thousand).

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES